All posts tagged
The Top 12 Biotech Leaders you should know in Basel
World Immunotherapy Congress 2016
World Biosimilar Congress Europe 2016
Tailored Cancer Vaccines? NousCom is working on it!
Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment
Interview: This Biotech could have the first HIV Cure on the Market
CRISPR Therapeutics applies to go Public in another Massive IPO
Could Artificial Enzymes be the Future of Synthetic Chemistry?
Meet the Biotech successfully using Bacteria for Immuno-Oncology
CAR-T Phase II: 93% Complete Remission in Children with Relapsed Leukemia!
No, Novartis and Roche won’t merge (yet)!
A Cartridge system to revolutionize diagnosis time of infective pathogens?
Labiotech UG, All Rights Reserved -
Send this to friend